发布求助
文献互助 智能选刊 最新文献

Biomarkers in medicine最新文献

筛选
英文 中文
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer. KELIM 评分可预测铂类耐药/难治性复发性卵巢癌患者的预后。
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-06-17 DOI: 10.1080/17520363.2024.2352409
Pauline Corbaux, Olivier Colomban, Aurore Carrot, Benoit You
{"title":"KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer.","authors":"Pauline Corbaux, Olivier Colomban, Aurore Carrot, Benoit You","doi":"10.1080/17520363.2024.2352409","DOIUrl":"10.1080/17520363.2024.2352409","url":null,"abstract":"","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"509-510"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11364077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood-based biomarkers and novel technologies for the diagnosis of colorectal cancer and adenomas: a narrative review. 诊断结直肠癌和腺瘤的血液生物标记物和新技术：综述。
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-06-20 DOI: 10.1080/17520363.2024.2345583
Drew Magowan, Mansour Abdulshafea, Dominic Thompson, Shri-Ishvarya Rajamoorthy, Rhiannon Owen, Dean Harris, Susan Prosser
{"title":"Blood-based biomarkers and novel technologies for the diagnosis of colorectal cancer and adenomas: a narrative review.","authors":"Drew Magowan, Mansour Abdulshafea, Dominic Thompson, Shri-Ishvarya Rajamoorthy, Rhiannon Owen, Dean Harris, Susan Prosser","doi":"10.1080/17520363.2024.2345583","DOIUrl":"10.1080/17520363.2024.2345583","url":null,"abstract":"<p><p><b>Aim:</b> Blood-based biomarkers have shown promise for diagnosing colorectal cancer (CRC) and adenomas (CRA). This review summarizes recent studies in this area. <b>Methods:</b> A literature search was undertaken for 01/01/2017-01/03/2023. Criteria included CRC, CRA, liquid-biopsy, blood-based tests and diagnosis. <b>Results:</b> 12,378 studies were reduced to 178 for data extraction. Sixty focused on proteomics, 53 on RNA species, 30 on cfDNA methylation, seven on antigens and autoantibodies and 28 on novel techniques. 169 case control and nine cohort studies. Number of participants ranged 100-54,297, mean age 58.26. CRC sensitivity and specificity ranged 9.10-100% and 20.40-100%, respectively. CRA sensitivity and specificity ranged 8.00-95.70% and 4.00-97.00%, respectively. <b>Conclusion:</b> Sensitive and specific blood-based tests exist for CRC and CRA. However, studies demonstrate heterogenous techniques and reporting quality. Further work should concentrate on validation and meta-analyzes.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"493-506"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11285240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141426365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High PLK3 levels are linked with less tumor invasion, lower FIGO stage and better prognosis of endometrial cancer. 高水平的 PLK3 与子宫内膜癌的较少肿瘤侵袭、较低的 FIGO 分期和较好的预后有关。
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-05-24 DOI: 10.1080/17520363.2024.2347192
Weiyue Zhou, Jurong Wang, Fen Tian, Ping Liu, Meiyan Li, Chunli Song, Yixin Zhang, Xiaoming Yang, Xiaohuan Nie, Yuanyuan Shi
{"title":"High PLK3 levels are linked with less tumor invasion, lower FIGO stage and better prognosis of endometrial cancer.","authors":"Weiyue Zhou, Jurong Wang, Fen Tian, Ping Liu, Meiyan Li, Chunli Song, Yixin Zhang, Xiaoming Yang, Xiaohuan Nie, Yuanyuan Shi","doi":"10.1080/17520363.2024.2347192","DOIUrl":"10.1080/17520363.2024.2347192","url":null,"abstract":"<p><p><b>Aim:</b> To evaluate correlations of tumor PLK3 with clinical features and prognosis of resectable endometrial cancer (EC) patients.<b>Methods:</b> Tumor tissues from 200 EC patients receiving surgical resections and adjacent tissues from 50 of them were collected for PLK3 determination using immunohistochemistry.<b>Results:</b> Tumor PLK3 negatively linked with myometrial invasion ≥50%, lymphovascular invasion, stromal cervical invasion, and International Federation of Gynecology and Obstetrics stage (all p < 0.050). High tumor PLK3 independently related to longer disease-free survival (DFS) (p = 0.044) and overall survival (OS) (p = 0.049). Its prognostic value was also validated by time-dependent receiver operating characteristic analyses (area under curve at most timepoints was >0.700).<b>Conclusion:</b> Tumor PLK3 potentially reflects prolonged DFS and OS in EC patients undergoing surgical resections.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"523-533"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11364079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141854836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
B-type natriuretic peptide levels at admission predict the prognosis of patients with infective endocarditis undergoing cardiac surgery. 入院时的 B 型钠尿肽水平可预测接受心脏手术的感染性心内膜炎患者的预后。
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-02-15 DOI: 10.2217/bmm-2023-0590
Ning Sun, Junyong Zhao, Wenjian Luo, Xiaolin Luo, Shaofa Wu, Zelan Wang, Pengda Li, Jia Li, Renjie Zhou, Shulin Ou, Zhexue Qin
{"title":"B-type natriuretic peptide levels at admission predict the prognosis of patients with infective endocarditis undergoing cardiac surgery.","authors":"Ning Sun, Junyong Zhao, Wenjian Luo, Xiaolin Luo, Shaofa Wu, Zelan Wang, Pengda Li, Jia Li, Renjie Zhou, Shulin Ou, Zhexue Qin","doi":"10.2217/bmm-2023-0590","DOIUrl":"10.2217/bmm-2023-0590","url":null,"abstract":"<p><p><b>Purpose:</b> The objective of this study was to explore the relationship between elevated B-type natriuretic peptide (BNP) levels and the prognosis of patients with infective endocarditis (IE) undergoing cardiac surgery. <b>Methods:</b> In total, 162 IE patients with recorded BNP levels upon admission were included in the present study. The primary end point was all-cause mortality. <b>Results:</b> Multivariate Cox analysis revealed a significant association between log BNP and all-cause mortality. Kaplan-Meier analysis revealed a poorer prognosis for patients with BNP levels ≥ the 75th percentile. Furthermore, the linear trend test indicated a significant link between BNP quartiles and the primary end point within the models. <b>Conclusion:</b> Elevated BNP levels upon admission could predict all-cause mortality in IE patients undergoing cardiac surgery.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"93-102"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139734529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traditional and nontraditional lipid parameters in Helicobacter pylori infection. 幽门螺旋杆菌感染的传统和非传统血脂参数
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-06-12 DOI: 10.2217/bmm-2023-0453
Selcuk Ozturk, Muhammed A Dursun, Tekin Yildirim, Fatih Sargin, Zeynep G Sargin, Zeynep T Ozan
{"title":"Traditional and nontraditional lipid parameters in <i>Helicobacter pylori</i> infection.","authors":"Selcuk Ozturk, Muhammed A Dursun, Tekin Yildirim, Fatih Sargin, Zeynep G Sargin, Zeynep T Ozan","doi":"10.2217/bmm-2023-0453","DOIUrl":"10.2217/bmm-2023-0453","url":null,"abstract":"<p><p><b>Aims:</b> This study sought to evaluate the relationship between <i>Helicobacter pylori</i> infection and traditional and nontraditional lipid parameters, including atherogenic index of plasma, cardiogenic risk ratio, atherogenic coefficient and remnant cholesterol. <b>Methods:</b> After the application of exclusion criteria, 309 patients were allocated according to the absence (n = 52) or presence (n = 257) of <i>H. pylori</i> infection. <b>Results:</b> Total cholesterol, low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) levels were nonsignificantly higher, and HDL-C levels were nonsignificantly lower, in the <i>H. pylori</i>-infected patient group. Triglyceride-to-HDL-C ratio, LDL-C-to-HDL-C ratio, atherogenic index of plasma, cardiogenic risk ratio, atherogenic coefficient and remnant cholesterol were comparable among groups. <b>Conclusion:</b> There was no significant association between <i>H. pylori</i> infection and traditional and nontraditional novel lipid parameters and indices.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"291-300"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140288242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of primary markers of inflammation and the systemic inflammation index in specific learning disabilities. 评估特殊学习障碍的主要炎症指标和全身炎症指数。
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.1080/17520363.2024.2404387
Pınar Aydoğan Avşar, Tayfun Kara, Orhan Kocaman, Merve Akkuş
{"title":"Evaluation of primary markers of inflammation and the systemic inflammation index in specific learning disabilities.","authors":"Pınar Aydoğan Avşar, Tayfun Kara, Orhan Kocaman, Merve Akkuş","doi":"10.1080/17520363.2024.2404387","DOIUrl":"10.1080/17520363.2024.2404387","url":null,"abstract":"<p><p><b>Aim:</b> Specific learning disorder (SLD) is a term that refers to reading, writing and arithmetic difficulties. The neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and systemic inflammation index (SII) are affordable and accessible inflammatory biomarkers. This research aims to evaluate the relationship between NLR, PLR, SII and SLD to determine whether inflammation contributes to pathogenesis.<b>Methods:</b> This study included 90 SLD-diagnosed patients and 90 age-, sex- and ethnicity-matched healthy controls. Blood cell counts and NLR, PLR and SII values were obtained from medical records and compared between the two groups.<b>Results:</b> The NLR, PLR and SII were significantly higher (<i>p</i> = 0.029, <i>p</i> = 0.033 and <i>p</i> = 0.018 respectively) and lymphocyte counts were significantly lower (<i>p</i> = 0.041) in the SLD group. WISC-R total scores decreased with age in the SLD group (-1.988 coefficient, Beta = -0.247 ß, <i>p</i> = 0.041). Multivariate logistic regression analysis revealed that the SII was the only parameter independently associated with the diagnosis of SLD (Beta = 0.003, <i>p</i> = 0.023).<b>Conclusion:</b> Inflammation might play a role in SLD etiopathogenesis. NLR, PLR and SII may be potential biomarkers for SLD in children. Further research may lead to early diagnosis and additional anti-inflammatory pharmacological therapies for SLDs.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"907-916"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11509046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood MALT1 reflects acute exacerbation risk and inflammation in elderly chronic obstructive pulmonary disease patients. 血液中的 MALT1 反映了老年慢性阻塞性肺病患者的急性加重风险和炎症。
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-08-13 DOI: 10.1080/17520363.2024.2347199
Cui Liu, Jinsong Zhu, Lei Zhao, Guanying Li, Jiawei Sun, Shengli Zhang, Xijun Liang
{"title":"Blood <i>MALT1</i> reflects acute exacerbation risk and inflammation in elderly chronic obstructive pulmonary disease patients.","authors":"Cui Liu, Jinsong Zhu, Lei Zhao, Guanying Li, Jiawei Sun, Shengli Zhang, Xijun Liang","doi":"10.1080/17520363.2024.2347199","DOIUrl":"10.1080/17520363.2024.2347199","url":null,"abstract":"<p><p><b>Aim:</b> This study intended to investigate the ability of blood <i>MALT1</i> to estimate acute exacerbation risk in elderly chronic obstructive pulmonary disease (COPD) patients.<b>Methods:</b> Blood <i>MALT1</i> was detected in 176 elderly COPD patients (aged more than 60 years).<b>Results:</b> <i>MALT1</i> was elevated in patients with COPD acute exacerbation versus patients with stable COPD (<i>p</i> < 0.001). In patients with COPD acute exacerbation, <i>MALT1</i> was negatively related to forced expiratory volume in 1 s (FEV<sub>1</sub>)/forced vital capacity (FVC) (<i>p</i> = 0.024) and FEV<sub>1</sub>% predicted (<i>p</i> = 0.002), but positively linked with global initiative for chronic obstructive lung disease stage (<i>p</i> = 0.005).<b>Conclusion:</b> Blood <i>MALT1</i> reflects increased acute exacerbation risk and inflammation in elderly COPD patients.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"513-521"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11364060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies. 胆道癌症免疫疗法反应的新兴生物标志物：免疫检查点抑制剂策略综述。
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-08-15 DOI: 10.1080/17520363.2024.2385297
Yidan Lou, Yijing Chen, Kaibo Guo, Binbin Li, Song Zheng
{"title":"Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies.","authors":"Yidan Lou, Yijing Chen, Kaibo Guo, Binbin Li, Song Zheng","doi":"10.1080/17520363.2024.2385297","DOIUrl":"10.1080/17520363.2024.2385297","url":null,"abstract":"<p><p>Biliary tract cancers (BTCs) have rising incidence and mortality rates. Chemotherapy's limited efficacy has led to exploring new treatments like immunotherapy. which offers modest benefits. Moreover, the identification of reliable predictive biomarkers for immune checkpoint therapy in BTCs remains elusive, hindering personalized treatment strategies. This review provides an overview of the current landscape of emerging biomarkers for immunotherapy response in BTCs. We discuss the incremental benefits of combination therapy and the evolving role of immunotherapy in managing advanced BTC. Additionally, we highlight the need for robust predictive biomarkers to optimize treatment outcomes and foster a more individualized approach to patient care. We aim to identify promising research avenues and strategies to enhance therapeutic efficacy and patient survival in BTCs.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"703-715"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11441040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the effect of uric acid/albumin ratio on coronary slow flow with other inflammation-based markers. 尿酸/白蛋白比值对冠状动脉慢血流的影响与其他炎症指标的比较。
IF 2.2 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-02-07 DOI: 10.2217/bmm-2023-0386
Kenan Toprak, Kaya Özen, Tolga Memioğlu, Mehmet İnanır, Mustafa Kaplangöray, Selahattin Akyol, Mustafa B Tascanov, Asuman Biçer, Recep Demirbağ
{"title":"Comparison of the effect of uric acid/albumin ratio on coronary slow flow with other inflammation-based markers.","authors":"Kenan Toprak, Kaya Özen, Tolga Memioğlu, Mehmet İnanır, Mustafa Kaplangöray, Selahattin Akyol, Mustafa B Tascanov, Asuman Biçer, Recep Demirbağ","doi":"10.2217/bmm-2023-0386","DOIUrl":"10.2217/bmm-2023-0386","url":null,"abstract":"<p><p><b>Background:</b> Many inflammation-based markers (IBMs) have been shown to be closely related to coronary slow flow (CSF), but the effect of the uric acid/albumin ratio (UAR) on CSF and its relationship with other IBMs are not clearly known. In this study, we aimed to compare the effects of UAR and other IBMs on CSF. <b>Methods:</b> After the exclusion criteria, 126 patients with CSF detected on coronary angiography and 126 subjects with normal coronary flow as the control group were included in the study. <b>Results:</b> UAR was determined as an independent predictor for CSF. In addition, the UAR was superior to other IBMs in detecting CSF (p < 0.05 for all). <b>Conclusion:</b> This study is the first to investigate the effect of UAR on CSF in comparison with other IBMs.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"25-37"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139696861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia. 血清 miR-4793-3p 和 miR-1180-3p 表达对社区获得性肺炎的诊断预测能力。
IF 1.9 4区 医学
Biomarkers in medicine Pub Date : 2024-01-01 Epub Date: 2024-03-08 DOI: 10.2217/bmm-2023-0463
Rong Chai, Cihang Zhou, Zhenli Hu, Jingjing Hu
{"title":"Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia.","authors":"Rong Chai, Cihang Zhou, Zhenli Hu, Jingjing Hu","doi":"10.2217/bmm-2023-0463","DOIUrl":"10.2217/bmm-2023-0463","url":null,"abstract":"<p><p><b>Background:</b> Early identification of community-acquired pneumonia (CAP) is crucial to prevent severe progression. <b>Methods:</b> The authors enrolled 150 hospitalized CAP patients and collected clinicopathologic features and blood indicators. Plasma miRNA profiling was conducted using microarray detection, and selected miRNAs were tested with reverse transcription quantitative PCR. Predictive models were built using least shrinkage and selection operator regression. <b>Results:</b> Least shrinkage and selection operator regression identified two miRNAs (miR-4793-3p and miR-1180-3p) that distinguished mild from severe CAP patients (area under the curve = 0.948). The miRNA model outperformed D-dimer, platelet and procalcitonin (max area under the curve = 0.729). <b>Conclusion:</b> Increased levels of miR-4793-3p and miR-1180-3p may indicate severe pneumonia development. Plasma miRNA profiling enables early prediction of severe CAP, aiding therapeutic decisions.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"231-241"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11216277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信